IPG Photonics Corp. Stock Slides 3.4%, Underperforms Market
Dow Jones2026/08/24 20:35This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of IPG Photonics Corp. slid 3.4% to $70.74 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.3% to 53,417.16 and the S&P 500 Index falling 0.3% to 7,652.86.
This was the stock's fifth consecutive day of losses.
IPG Photonics Corp. closed 54.6% below its 52-week high of $155.82, which the company reached on February 13th.
The stock demonstrated a mixed performance when compared to some of its peers, as Teradyne Inc. fell 2.9% to $364.90, Lumentum Holdings Inc. fell 4.2% to $830.17, and nLIGHT Inc. fell 6.92% to $44.11.
Trading volume totaled 753,724, compared to the 50-day average of 433,992.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 24, 2026 16:35 ET (20:35 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Signs of Strength in U.S. Economy Power Stocks -- WSJ
Silver Price Forecast: XAG/USD remains vulnerable near $60

BMO analyst: The cooling of inflation exceeded expectations
Roche (RHHBY.US) BTK inhibitor submitted for listing
On September 30, Roche (RHHBY.US) announced that the U.S. FDA has accepted the New Drug Application (NDA) for its non-covalent BTK inhibitor, fenebrutinib.